Anastrozole Tablet, Coated
Product Images NDC 72789-342

8 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 72789-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 01)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 01)
Chemical structure diagram of anastrozole, showing its molecular arrangement with nitrogen-containing rings and cyano groups attached to a benzene ring.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 02)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 02)
A Kaplan-Meier survival curve chart comparing disease-free survival over time in months between patients treated with anastrozole and tamoxifen. The y-axis represents the proportion of patients alive and disease-free, while the x-axis indicates disease-free survival in months, up to 90 months. Patient risk numbers at various time points are shown below the graph for each treatment group.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 03)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 03)
A survival curve chart comparing disease-free survival in months between anastrozole and tamoxifen treatments. The y-axis shows the proportion alive and disease-free, while the x-axis shows time up to 90 months. The chart includes the number of patients at risk for each treatment group over time.*
FDA Label Image

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 04)

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 04)
A Kaplan-Meier survival curve chart comparing the proportion of event-free patients over time in months for Anastrozole and Tamoxifen treatments. The chart includes lines representing each treatment group and a table below showing the number of patients at risk at various time points from 0 to 120 months. The vertical axis represents the proportion event-free, truncated between 0.50 and 1.00 for clarity.*
FDA Label Image

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 05)

Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 05)
Kaplan-Meier survival curve chart showing the proportion of patients event-free over time in months, comparing randomized treatment with Anastrozole versus Tamoxifen. The x-axis represents time to event in months up to 120 months, and the y-axis shows the proportion event-free, truncated between 0.50 and 1.0. Patient numbers at risk are listed below the graph at specified monthly intervals.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 06)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 06)
A line graph showing the proportion of patients not progressing over time in months for two treatments, Anastrozole and Tamoxifen. The y-axis represents the proportion not progressing from 0.0 to 1.0, and the x-axis displays time to progression in months, ranging from 0 to 42. The graph includes a legend differentiating the treatments by line style and a table of patient numbers at risk at various time points below the x-axis.*
FDA Label Image

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 07)

Structured Formula For Anastrozole Tablets (577b7171 5da0 4291 Af07 5e4653ffb3aa 07)
A Kaplan-Meier survival curve chart comparing time to progression in months for two randomized treatments: Anastrozole and Tamoxifen. The y-axis shows the proportion not progressing, and the x-axis shows time in months up to 40 months. A table below shows the number of patients at risk at various time points for each treatment group.*
FDA Label Image

72789342 Label (72789342)

72789342 Label (72789342)
Label for Anastrozole USP 1 mg coated tablets, 15 tablets per container. The label includes a warning to keep out of reach of children and a note that the product is Rx only. The labeler is PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. Additional information includes the National Drug Code (NDC) 72789-342-15, lot number C29045, and expiration date 12/2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.